HEALTHY VOLUNTEERS

This early-stage study tested a new drug called ASP5502 in healthy adults and people with Sjögren's syndrome, a condition where the immune system attacks moisture-producing glands. The main goal was to check safety and how well the drug is tolerated. The study was terminated, so …

This study tested an experimental drug (PF-07258669) to help older adults who lose weight without trying. The goal was to see if the drug is safe and can improve appetite and weight. The trial was stopped early and included only 7 people aged 60 to 90.

This study tested whether a single session of non-invasive brain stimulation (alpha-tACS) could make people more flexible in their habits. Seven healthy adults, including some with risky drinking histories, received either real or fake stimulation while performing a computer task…

This study aimed to create better MRI images of the lungs by having healthy volunteers inhale special tracer gases. Researchers tested new hardware and software to improve image quality. The study involved 24 healthy people aged 6 to 75 and did not change their regular medical ca…

This study looked at two new liquid versions of the drug maribavir, designed for children, to see how well they are absorbed and taste compared to the current tablet. It involved 20 healthy adults and was stopped early. The goal was to gather information, not to treat a disease.

This early-stage study aimed to check if the experimental drug AMG 378 is safe and tolerable in healthy adults aged 18 to 55. Participants received either single or multiple doses of the drug or a placebo. The study was terminated early, so no results on safety or how the drug be…

This study looked at whether a mindfulness training program could change brain connections in teenagers who vape tobacco. Researchers used brain scans to measure changes before and after training, and also asked teens about their vaping habits. The goal was to see if mindfulness …

This study looked at how healthy adults respond to breathing air with less oxygen for up to 7 days. Researchers measured oxygen levels in the blood and checked for changes in red blood cell production and lung pressure. The goal was to understand the body's safety and reactions t…

This early-stage study tested a new drug called iCP-NI in healthy adults to see if it is safe and how the body processes it. Participants received one or more doses of the drug or a placebo by IV. The study was stopped early, and it does not aim to treat any disease.